Literature DB >> 10997339

T cells recognize an immunodominant epitope of heat shock protein 65 in Kawasaki disease.

G Sireci1, F Dieli, A Salerno.   

Abstract

BACKGROUND: Kawasaki disease (KD) is an acute systemic vasculitis of infancy and early childhood that is characterized by endothelial cell damage associated with T-cell activation. Lymphocytes infiltrating damaged tissues might be responsible for the disease through secretion of cytokines, such as tumor necrosis factor (TNF)-alpha, that could cause fever, as well as endothelial tissue damage. Debate is growing about the nature of antigen responsible for T-cell activation in KD. Bacillus Calmette Guerin (BCG) and purified protein derivative (PPD) hyperresponsiveness was observed in KD patients and this phenomenon was hypothetically ascribed to cross-reactivity between mycobacterial Heat Shock Protein (HSP) 65 and human homologue HSP63.
MATERIALS AND METHODS: CD4+ and CD8+ T-cell clones were obtained from peripheral blood of KD patients in acute phase, or control subjects. The clones were tested for reactivity toward HSP65 and derived peptides. Both proliferation and cytokine production were analyzed.
RESULTS: A significant fraction of CD4 and CD8 T-cell clones from KD patients recognized an epitope from HSP65, spanning amino acids 65-85. T-cell clones cross-reacted with the corresponding 90-110 peptide sequence of human HSP-63.
CONCLUSIONS: Cross-reactivity between specific epitopes of mycobacterial and human HSP could play a role in the development of the tissue-damage characteristic of KD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997339      PMCID: PMC1949968     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  21 in total

1.  Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research.

Authors:  P A Brogan; A Bose; D Burgner; D Shingadia; R Tulloh; C Michie; N Klein; R Booy; M Levin; M J Dillon
Journal:  Arch Dis Child       Date:  2002-04       Impact factor: 3.791

Review 2.  The Quality of Practice Committee of the RCPCH.

Authors:  N McIntosh; J H Baumer
Journal:  Arch Dis Child       Date:  2005-09       Impact factor: 3.791

3.  Inflammation at a previous inoculation site: an unusual presentation of Kawasaki disease.

Authors:  Michael Weinstein
Journal:  CMAJ       Date:  2006-02-14       Impact factor: 8.262

4.  BCG and Kawasaki disease in Mexico and Japan.

Authors:  Luisa Berenise Gamez-Gonzalez; Hiromichi Hamada; Beatriz Adriana Llamas-Guillen; Miguel Ruiz-Fernandez; Marco Yamazaki-Nakashimada
Journal:  Hum Vaccin Immunother       Date:  2017-03-10       Impact factor: 3.452

5.  Incomplete Kawasaki disease: The usefulness of BCG reactivation as a diagnostic tool.

Authors:  Omer S M Suliman; Mohamed Abdelnasser
Journal:  Sudan J Paediatr       Date:  2012

6.  CLINICAL MANAGEMENT OF LOCALIZED BCG ADVERSE EVENTS IN CHILDREN.

Authors:  Thais das Neves Fraga Moreira; Maria Isabel de Moraes-Pinto; Beatriz Tavares Costa-Carvalho; Anete Sevciovic Grumach; Lily Yin Weckx
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-11-03       Impact factor: 1.846

7.  Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease.

Authors:  Cristina Novais; Fabiana Fortunato; Anabela Bicho; Luísa Preto
Journal:  BMJ Case Rep       Date:  2016-03-31

8.  Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu's arteritis.

Authors:  S Kumar Chauhan; N Kumar Tripathy; N Sinha; M Singh; S Nityanand
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

Review 9.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

10.  Desquamation in Kawasaki Disease.

Authors:  Ling-Sai Chang; Ken-Pen Weng; Jia-Huei Yan; Wan-Shan Lo; Mindy Ming-Huey Guo; Ying-Hsien Huang; Ho-Chang Kuo
Journal:  Children (Basel)       Date:  2021-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.